Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI

Lancet

Volumn 353, Issue 9169, 1999, Pages 2036-2037

  Jansen, Olav ^a   Schellinger, Peter ^a   Fiebach, Jochen ^a   Hacke, Werner ^a   Sartor, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; RECANALIZATION;

EID: 0033549382     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01146-0     Document Type: Article

References (5)

1. Hacke W., Kaste M., Fieschi C.et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemia stroke (ECASS II). Lancet. 352:1998;1245-1251.
2. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med. 333:1995;1581-1587.
3. Fisher M. Characterizing the target of acute stroke therapy. Stroke. 28:1997;866-872.
4. Lovblad K.O., Baird A.E., Schlaug G.et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 42:1997;164-170.
5. Warach S., Dashe J.F., Edelman R.R. Clinical outcome in ischaemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 16:1996;53-59.